| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Dec 11, 2024 |
|||||||||
| Q4 FY24 | $4.81 | $4.66 | $5.61B | $5.54B |
NASDAQ |
||||
| Q3 FY24 | $0.04 | -$0.01 | $4.90B | $4.74B |
NYSE |
||||
|
Nordson
NDSN
|
- | $2.78 | $2.59 | $744.48M | $736.83M |
NASDAQ |
|||
|
REV Group
REVG
|
Q4 FY24 | $0.51 | $0.49 | $597.90M | $603.33M |
NYSE |
|||
|
Oxford Industries
OXM
|
Q3 FY24 | -$0.11 | $0.11 | $308.03M | $312.13M |
NYSE |
|||
|
Photronics
PLAB
|
Q4 FY24 | $0.59 | $0.52 | $222.63M | $218M |
NASDAQ |
|||
|
J.Jill
JILL
|
Q3 FY24 | $0.89 | $0.80 | $151.26M | $142.38M |
NYSE |
|||
|
Vera Bradley
VRA
|
Q3 FY25 | -$0.27 | $0.06 | $80.58M | $98.70M |
NASDAQ |
|||
|
Kewaunee Scientific
KEQU
|
- | $1.41 | - | $47.76M | - |
NASDAQ |
|||
|
Timberland Bancorp
TSBK
|
- | $0.80 | - | $26.82M | - |
NASDAQ |
|||
|
Champions Oncology
CSBR
|
Q2 FY25 | $0.05 | $0.01 | $13.49M | $13.05M |
NASDAQ |
|||
|
Hennessy Advisors
HNNA
|
- | $0.30 | - | $8.78M | - |
NASDAQ |
|||
|
Rafael Holdings
RFL
|
- | -$0.37 | - | $128K | - |
NYSE |
|||
|
Alzamend Neuro
ALZN
|
- | -$3.60 | -$21.42 | - | - |
NASDAQ |
|||
| Show 4 more companies | |||||||||
